Subsequently, due to the chronic state of moderate hyperglycemia, the upregulation of ACE1/Ang II signalling persists, thus worsening insulin resistance, glucose tolerance, and inflammation, as evidenced by the significantly increased ACE1/Ang II, HOMA-IR, and MCP-1 in T2DM. This evidence concerns the gene CCL2 and Hyperglycemia.